Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry von Lichtenstein, Gary R., Feagan, Brian G., Cohen, Russell D., Salzberg, Bruce A., Diamond, Robert H., Chen, Donny M., Pritchard, Michelle L., Sandborn, William J.

Volltext

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients von Colombel, Jean-Frederic, Loftus, Jr, Edward V, Tremaine, William J, Egan, Laurence J, Harmsen, W Scott, Schleck, Cathy D, Zinsmeister, Alan R, Sandborn, William J

Volltext

Correlation of C‐reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease von Solem, Craig A, Loftus, Edward V, Tremaine, William J, Harmsen, William S, Zinsmeister, Alan R, Sandborn, William J

Volltext

Anti–Interleukin-12 Antibody for Active Crohn's Disease von Mannon, Peter J, Fuss, Ivan J, Mayer, Lloyd, Elson, Charles O, Sandborn, William J, Present, Daniel, Dolin, Ben, Goodman, Nancy, Groden, Catherine, Hornung, Ronald L, Quezado, Martha, Neurath, Markus F, Salfeld, Jochen, Veldman, Geertruida M, Schwertschlag, Ullrich, Strober, Warren

Volltext

The epidemiology and natural history of Crohn’s disease in population‐based patient cohorts from North America: a systematic review von Loftus, E. V., Schoenfeld, P., Sandborn, W. J.

Volltext

CDP571, a humanised monoclonal antibody to tumour necrosis factor α, for moderate to severe Crohn’s disease: a randomised, double blind, placebo controlled trial von Sandborn, W J, Feagan, B G, Radford-Smith, G, Kovacs, A, Enns, R, Innes, A, Patel, J

Volltext

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease von Sandborn, William J., Feagan, Brian G., Hanauer, Stephen B., Lochs, Herbert, Lofberg, Robert, Modigliani, Robert, Present, Daniel H., Rutgeerts, Paul, Scholmerich, Jurgen, Stange, Eduard F., Sutherland, Lloyd R.

Volltext

Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot Study von Sandborn, William J., Stenson, William F., Brynskov, Jørn, Lorenz, Robin G., Steidle, Gina M., Robbins, Jeffery L., Kent, Jeffery D., Bloom, Bradley J.

Volltext

Crohn's disease von Baumgart, Daniel C, Prof, Sandborn, William J, Prof

Volltext

Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide von Lowry, P W, Franklin, C L, Weaver, A L, Szumlanski, C L, Mays, D C, Loftus, E V, Tremaine, W J, Lipsky, J J, Weinshilboum, R M, Sandborn, W J

Volltext

Budesonide as maintenance treatment in Crohn's disease: a placebo‐controlled trial von Hanauer, S., Sandborn, W. J., Persson, A., Persson, T.

Volltext

Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease von Sandborn, W J, Loftus, E V

Volltext

Ulcerative colitis von Ordás, Ingrid, MD, Eckmann, Lars, Prof, Talamini, Mark, Prof, Baumgart, Daniel C, Prof, Sandborn, William J, Prof Dr

Volltext

State of the art: IBD therapy and clinical trials in IBD von Isaacs, Kim L, Lewis, James D, Sandborn, William J, Sands, Bruce E, Targan, Stephan R

Volltext

Inflammatory bowel disease: clinical aspects and established and evolving therapies von Baumgart, Daniel C, Dr, Sandborn, William J, Prof

Volltext

Strategies for targeting tumour necrosis factor in IBD von Sandborn, William J

Volltext

Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease von Mahadevan, Uma, Loftus, Edward V, Tremaine, William J, Sandborn, William J

Volltext

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease von Sandborn, William J., Tremaine, William J., Wolf, Douglas C., Targan, Stephan R., Sninsky, Charles A., Sutherland, Lloyd R., Hanauer, Stephen B., McDonald, John W.D., Feagan, Brian G., Fedorak, Richard N., Isaacs, Kim L., Pike, M.Gennette, Mays, Dennis C., Lipsky, James J., Gordon, Susan, Kleoudis, Christi S., Murdock, Robert H.

Volltext

Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis von Sandborn, William J, Feagan, Brian G, Marano, Colleen, Zhang, Hongyan, Strauss, Richard, Johanns, Jewel, Adedokun, Omoniyi J, Guzzo, Cynthia, Colombel, Jean-Frederic, Reinisch, Walter, Gibson, Peter R, Collins, Judith, Järnerot, Gunnar, Hibi, Toshifumi, Rutgeerts, Paul

Volltext

Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis von Sandborn, William J, Feagan, Brian G, Marano, Colleen, Zhang, Hongyan, Strauss, Richard, Johanns, Jewel, Adedokun, Omoniyi J, Guzzo, Cynthia, Colombel, Jean–Frederic, Reinisch, Walter, Gibson, Peter R, Collins, Judith, Järnerot, Gunnar, Rutgeerts, Paul

Volltext